Senate Panel Advances Trump’s Nominee for FDA Commissioner
A Senate panel on Tuesday advanced President Donald Trump’s nomination of Dr. Stephen Hahn to be the next Food and Drug Administration commissioner, according to a CNBC report.
The Senate Committee on Health, Education, Labor and Pensions approved Hahn’s nomination in an 18 to 5 vote, sending his nomination to the full Senate. If confirmed, Hahn will join the FDA at a time when the spotlight is on the agency. Democrats grilled Hahn in his confirmation hearing last month about how he would curb a teen vaping epidemic. Multiple senators, including some Republicans, pushed Hahn to take a stance on banning flavored e-cigarettes. The Trump administration in September announced its plan to pursue such a ban before backtracking later in the fall.
